These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11291021)

  • 1. Pathophysiology and treatment of secondary obsessive-compulsive behaviors and tics.
    Bhangoo RK
    Semin Clin Neuropsychiatry; 2000 Oct; 5(4):250-8. PubMed ID: 11291021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tics and Gilles de la Tourette syndrome].
    Tijero-Merino B; Gómez-Esteban JC; Zarranz JJ
    Rev Neurol; 2009 Jan; 48 Suppl 1():S17-20. PubMed ID: 19222010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between obsessive-compulsive disorders and diseases affecting primarily the basal ganglia.
    Maia AS; Barbosa ER; Menezes PR; Miguel Filho EC
    Rev Hosp Clin Fac Med Sao Paulo; 1999; 54(6):213-21. PubMed ID: 10881070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary approaches to pharmacotherapy in Tourette's syndrome and obsessive-compulsive disorder.
    Scahill L
    J Child Adolesc Psychiatr Nurs; 1996; 9(1):27-43. PubMed ID: 8696657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tics and Tourette's disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children.
    Leonard HL; Lenane MC; Swedo SE; Rettew DC; Gershon ES; Rapoport JL
    Am J Psychiatry; 1992 Sep; 149(9):1244-51. PubMed ID: 1503140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study.
    Scahill L; Riddle MA; King RA; Hardin MT; Rasmusson A; Makuch RW; Leckman JF
    J Child Adolesc Psychopharmacol; 1997; 7(2):75-85. PubMed ID: 9334893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.
    McDougle CJ; Goodman WK; Leckman JF; Price LH
    Psychiatr Clin North Am; 1993 Dec; 16(4):749-66. PubMed ID: 8309811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis.
    Mink JW
    Pediatr Neurol; 2001 Sep; 25(3):190-8. PubMed ID: 11587872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct structural changes underpin clinical phenotypes in patients with Gilles de la Tourette syndrome.
    Worbe Y; Gerardin E; Hartmann A; Valabrégue R; Chupin M; Tremblay L; Vidailhet M; Colliot O; Lehéricy S
    Brain; 2010 Dec; 133(Pt 12):3649-60. PubMed ID: 20959309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gilles de la Tourette's syndrome with and without obsessive-compulsive disorder compared with obsessive-compulsive disorder without tics: which symptoms discriminate?
    Cath DC; Spinhoven P; van Woerkom TC; van de Wetering BJ; Hoogduin CA; Landman AD; Roos RA; Rooijmans HG
    J Nerv Ment Dis; 2001 Apr; 189(4):219-28. PubMed ID: 11339317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does an imbalance between the dorsal and ventral striatopallidal systems play a role in Tourette's syndrome? A neuronal circuit approach.
    Groenewegen HJ; van den Heuvel OA; Cath DC; Voorn P; Veltman DJ
    Brain Dev; 2003 Dec; 25 Suppl 1():S3-S14. PubMed ID: 14980365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between types and severity of repetitive behaviors in Gilles de la Tourette's disorder and obsessive-compulsive disorder.
    Cath DC; Spinhoven P; van de Wetering BJ; Hoogduin CA; Landman AD; van Woerkom TC; Roos RA; Rooijmans HG
    J Clin Psychiatry; 2000 Jul; 61(7):505-13. PubMed ID: 10937609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome.
    Steeves TD; Fox SH
    Prog Brain Res; 2008; 172():495-513. PubMed ID: 18772048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapeutic challenges in treatment of a child with "the triad" of obsessive compulsive disorder, attention-deficit/hyperactivity disorder and Tourette's disorder.
    Rice T; Coffey B
    J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):176-9. PubMed ID: 25782100
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurobiology. Making sense of Tourette's.
    Olson S
    Science; 2004 Sep; 305(5689):1390-2. PubMed ID: 15353772
    [No Abstract]   [Full Text] [Related]  

  • 16. Exclusion of the 5-HT1A serotonin neuroreceptor and tryptophan oxygenase genes in a large British kindred multiply affected with Tourette's syndrome, chronic motor tics, and obsessive-compulsive behavior.
    Brett PM; Curtis D; Robertson MM; Gurling HM
    Am J Psychiatry; 1995 Mar; 152(3):437-40. PubMed ID: 7864272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood obsessive compulsive disorder.
    Rapoport JL; Swedo SE; Leonard HL
    J Clin Psychiatry; 1992 Apr; 53 Suppl():11-6. PubMed ID: 1564053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry.
    Nordstrom EJ; Burton FH
    Mol Psychiatry; 2002; 7(6):617-25, 524. PubMed ID: 12140785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary tics or tourettism associated with a brain tumor.
    Luat AF; Behen ME; Juhász C; Sood S; Chugani HT
    Pediatr Neurol; 2009 Dec; 41(6):457-60. PubMed ID: 19931171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cortical excitability in obsessive-compulsive disorder.
    Greenberg BD; Ziemann U; Corá-Locatelli G; Harmon A; Murphy DL; Keel JC; Wassermann EM
    Neurology; 2000 Jan; 54(1):142-7. PubMed ID: 10636140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.